COVID-19 vaccines: Pfizer-BioNTech shot likely to foil mutant, new study shows
Study on South Africa strain suggests some re-infection threat
Naomi Kresge and Janice Kew, Bloomberg
Jan. 20, 2021
FacebookTwitterEmail
Pfizer Inc. and BioNTech SE built the case that their Covid-19 vaccine will protect against the new variant of the coronavirus that emerged in the U.K. with results of another lab trial.
Like previous work out of the University of Texas Medical Branch, the results published on Wednesday showed that antibodies in the blood of people who had been vaccinated were able to neutralize a version of the mutant virus that was created in the lab. The study was published on preprint server BioRxiv prior to peer review.
Инвестор приступил к ремонту бассейна хабаровской гимназии № 8 | ДВ-РОСС — новости Дальнего Востока
trud-ost.ru - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from trud-ost.ru Daily Mail and Mail on Sunday newspapers.
La coalición de Gobierno admite enfoques distintos sobre la reforma energética
lavanguardia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lavanguardia.com Daily Mail and Mail on Sunday newspapers.
Estados Unidos distribuirá las dosis de las vacunas contra el COVID-19 que se encontraban retenidas para aplicar como refuerzo
infobae.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from infobae.com Daily Mail and Mail on Sunday newspapers.
El Congreso de EEUU ratifica a Biden como presidente electo | Noticias Diario de Ávila
diariodeavila.es - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from diariodeavila.es Daily Mail and Mail on Sunday newspapers.